Search fresh public links, source activity, and post angles for 2026 M&A.
Fresh curated links around 2026 M&A are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
M&A activity saw a stunning resurgence in the first quarter of 2026, with global deal value totaling a record $1.22 trillion, representing a 26% increase over the same period i...
Leaders from Coinbase, M13, and Mignano Law Group talk about how M&A is an early-stage strategy at TechCrunch Disrupt 2026. Register to hear this live.
Four contech giants added to their offerings while two builders prepared to strengthen their presence in growing markets.
Dealmaking is on the upswing, but sponsors need to rethink their methods to get to the finish line, writes Matthew Brohm of Arnall Golden Gregory. The post Healthcare M&A in 2...
This year, global mergers and acquisitions (M&A) dealmakers have powered through geopolitical tensions and trade policy uncertainty. In Q1 2026, total deal value reached an est...
The technology M&A market showed signs of recovery in late 2025 and early 2026 from the lows of 2023 and 2024, driven primarily by high-value transactions rather than increased...
This five-part series examines current trends in home health and hospice M&A as the sector enters 2026, including valuation discipline, compliance and clinical risk, the role o...
The biggest biotech acquisition deal so far in 2026 was announced in April. Deals were sealed over ADCs, small molecules, AI platforms, and T-cell engagers. The post Top biotech...
In 2025, we were happy to see ASIC and ASX respond to industry calls by taking some steps to streamline the IPO process, in particular, ASIC’s introduction of new fast track reform...
There were seven multibillion-dollar acquisitions that occurred in May 2026, although it was a quieter month on the biotech deals front. The post Top biotech deals in May 2026 app...
The life sciences M&A landscape in the first quarter of 2026 was defined by constrained capital markets, heightened investor selectivity, and increasingly sophisticated transac...
This five-part series examines current trends in home health and hospice M&A in 2026, including valuation discipline, compliance and clinical risk, the role of artificial intel...
A consulting and M&A advisory firm presented six prospective sellers to 17 buyers, with striking results for any advisory teams tapping into a frothy M&A market.
The latest deal adds 1,100 managed properties and three branches to the group
Sustained demand for senior living and development constraints are setting up increased transaction velocity for the remainder of this year. That’s according to the new Marcus and...
Marshberry's John Orsini explores how advisors can prepare for a potential acquisition.
May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion admin Tue, 05/26/2026 - 11:55 Lilly keeps pushing forward with deals and pipeline mome...
May 12 2026 - BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal admin Tue, 05/12/2026 - 12:10 Big deals lead the way today, with a massive BMS partners...
A report from the industry tracking-firm DeVoe & Co. finds that 2026 is off to the strongest start for RIA acquisitions ever and broker-dealers like LPL are among the main purc...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.